Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Regenerative Medicine Essentials
    • World Stem Cell Summit
    • Exploring Public Policy: Regenerative Medicine and Cell Therapies
    • Congressional Briefings
    • Regenerative Medicine and Stem Cell Action Awards
    • World Stem Cell Summit – CHINA
  • Membership/Donate
    • Membership
    • Donate
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
Select Page

California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients

by Kevin McMahon | Jan 18, 2018 | News & Opinions

January 18, 2018 – Oakland, CA Over 650,000 Americans suffer from end-stage kidney disease – a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney transplant from a genetically...

Recent Posts

  • Phase I clinical trial shows promise of adipose-derived stem cells in treating lymphedema
  • HCP Busted for Selling Fake Stem Cell Therapy
  • New institute to leverage experts to advance regenerative medicine
  • Karīna Narbute’s Research in Extracellular Vesicles Earns Her Young Investigator Award
  • Retinal cell transplant clears experimental hurdle toward treating blindness
Tweets about @WSCSummit
CC Regenerative Medicine Foundation